October 9, 2015
While far from being ratified, the announced successful conclusion of negotiations of the Trans-Pacific Partnership (TPP) trade deal may have brought a chill to a number of biotech players.
September 24, 2015
The UK has tightened regulation for clinical trials in recent years. Reaction from the industry has been strong, with some suggesting legislation and high costs will kill off research and development (R&D) innovation and clinical research in the UK – but there’s more to the issue than meets the eye.
September 11, 2015
The sands are shifting beneath Europe’s research and development (R&D) ecosystem. Key factors that underpin R&D in the region are evolving, from funding and IP laws to competitive pressures and research practice. All this brings about a new set of challenges and opportunities for research-driven organizations.
September 7, 2015
There’s no doubt that research and development oriented organizations have made huge strides to move beyond the limitations of paper-based working and embrace technologies that automate data capture, analysis and reporting. For those groups and organizations that have left paper behind, the gains in terms of time saved transcribing data from system to system, aggregating data for reports have been significant and measurable. These time savings and efficiency gains create the opportunities for scientists to focus on innovation rather than admin.
August 4, 2015
When it comes to research and development (R&D), money talks. More specifically, cost will always play a role in the type of technologies used in the lab – and the way those technologies are used. As the media has often highlighted this year, R&D organizations are under pressure to reduce costs, increase speed to market and drive innovation. That will have a profound impact on the technology they choose to support their scientists in the lab.